Swiss company Santhera Pharmaceuticals has inked a deal for Basel University spinoff SEAL Therapeutics to continue development of a novel gene ...
https://www.google.com/url?rct=j&sa=t&url=https://www.thepharmaletter.com/in-brief/brief-santhera-passes-gene-therapy-tech-to-basel-university-spinoff&ct=ga&cd=CAIyGmEyNDJjNTAxZWU3OTQyNzI6Y29tOmVuOlVT&usg=AFQjCNFahtbNadtREzpKif2oCMMMso5C_g
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.